Stocks · Korea
182400
KOSDAQ
NKGen Biotech Korea
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+0.00%
YTD+0.00%
52W high3,670원
52W low—
From 52W high+0.00%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 113억 | -497억 | -556억 | -440.9% |
| 2023 | 0원 | -673억 | -1,534억 | — |
| 2024 | 88억 | -41억 | -369억 | -46.2% |
| 2025 | 79억 | -25억 | -73억 | -32.2% |
| Quarterly | ||||
| 2024 4Q | 22억 | 46억 | 9억 | 204.6% |
| 2025 1Q | 14억 | -5억 | -77,269,700원 | -37.0% |
| 2025 2Q | 20억 | -9억 | 25억 | -44.8% |
| 2025 3Q | 22억 | 43,793,585원 | 2억 | 2.0% |
| 2025 4Q | 22억 | -11억 | -100억 | -51.7% |
| 2026 1Q | 16억 | -12억 | -13억 | -76.6% |
Company
Address: 경기도 수원시 영통구 창룡대로 440 -
Peers in the same sector
Recent filings
- 2026-09-30[기재정정]반기보고서 (2026.06)
- 2026-08-13반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.